5^th Global Pharmacists Annual Meeting July 14-15, 2016 Brisbane, Australia

The missions of the hospital pharmacists is to be part of the medication management in hospitals, which encompasses the entire way in which medicines are selected, procured, delivered, prescribed, administered and reviewed to optimise the contribution that medicines make to producing informed and desired outcomes to enhance the safety and quality of all medicine related processes affecting patients of the hospital to ensure the 7 “rights” are respected: right patient, right dose, right route, right time, right drug with the right information and documentation. The global inpatient and outpatient pharmacy automation market was valued at $2.4 billion in 2011 and should reach $2.6 billion in 2012. Total market value is expected to reach nearly $3.9 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8%.

Pharmacists provide an invaluable interface in this process by liaising with scientists and clinicians across the development arena. Within clinical research, pharmacists can help assess the safety and efficacy of new medicines. Skills learnt during pharmacy training allow them to contribute to the entire clinical trial process from planning the trial, developing the prototype formulations for administration first in animals and later for trials in humans, the production, packaging, labelling and supply of the medicine to clinical researchers, through to the monitoring and reporting of complex studies. In 2000, expenditure on research and development in United States, Europe and Japan countries came to a total of some 45 billion U.S. dollars.

Industrial pharmacy includes manufacturing, marketing and distribution of drug products including quality assurance of these activities. The statistic depicts the worldwide revenue of the pharmaceutical market from 2001 to 2014. In 2001, worldwide revenue was around 390.2 billion U.S. dollars. Ten years later, this figure stood at almost one trillion U.S. dollars.

Academic pharmacists engage in education, pharmaceutical practice, and research in schools of pharmacy. These three aspects of academic activity are interrelated, and at the same time connected with manpower planning and management. As of March 31, 2014 there were 48,815 pharmacists in Great Britain which is an increase of 2.96 percent on 2013.

Based on International Pharmaceutical Federation (FIP) the guidelines for Good Pharmaceutical Practice were first laid in 1993. And further used as reference by national pharmaceutical organisations, governments, and international pharmaceutical organizations to set up nationally accepted standards. The aim is  to "contribute to health improvement and to help patients with health problems to make the best use of their medicines. This statistic shows total medicines expenditure worldwide in 2010 and 2015, and provides a forecast for 2020. In 2010, total spending on medicine was 887 billion U.S. dollars. It is estimated that until 2020 the pharmaceutical market will increase to around 1.4 trillion U.S. dollars.

Community pharmacists are the health professionals most accessible to the public and other health professionals in primary health care. They supply medicines in accordance with a prescription or, when legally permitted, sell them without a prescription. In addition to ensuring an accurate supply of appropriate products, their professional activities also cover counselling of patients at the time of dispensing of prescription and non-prescription drugs, drug information to health professionals, patients and the general public, and participation in health-promotion programmes. In England in 2014/15 978.3 million items were dispensed by community pharmacies (92.1 per cent of all items dispensed in the community). This is an increase of 30.1 million (3.2 per cent) from 2013/14 when the figure was 948.2 million. This compares with 85.0 million items dispensed by dispensing practices and 7.8 million by appliance contractors in 2014/15. 14.7 per cent of items dispensed by community pharmacies and appliance contractors were via the Electronic Prescription Service.

Nuclear Pharmacy is a specialty practice of pharmacy defined as a patient-oriented service embodying the scientific knowledge and professional judgment required to improve and promote health through the safe and efficacious use of radioactive drugs for diagnosis and therapy. By 2015, total revenues of pharmaceutical and medicine manufacture in Canada are projected to reach approximately 10.69 billion U.S. dollars.

Ambulatory care pharmacy is a fairly new focus for pharmacists and work in both an institutional and community-based clinic involved in direct care of a diverse patient population. This statistic shows the channels consumers use for health care, personal care and pharmacy services when shopping in the United Kingdom (UK), as a percentage of survey respondents. Of respondents, 36 percent said they shopped out of town for health, personal care and pharmacy services. This survey was conducted in October 2013.

Home Care Pharmacy provides a large selection of healthcare and home medical equipment that helps public to be safe and independent in the home. This statistic shows the top therapy areas in developed pharmaceutical markets as projected in 2018, sorted by spending in billion US dollars. By 2018, expenditure on oncologists in these markets is projected to reach between 71 and 81 billion U.S. dollars.

A pharmacist working in a managed care environment is intimately involved in the care and course of pharmaceutical treatment and plays a vital role in contributing to positive patient outcomes.  The areas of opportunities for pharmacists to coordinate patient care include but are not limited to data integration, communication management with physicians and patient outcomes research efforts, drug utilization review, disease management, academic detailing, cost analysis programs, and pharmacy benefit design.  In addition, pharmacists are able to qualify and quantify the results of different therapies and programs, and therefore add value to the health care team. BCC estimates the total market for the clinical healthcare IT technologies covered in this report at more than $6.3 billion in 2010.  The market is projected to grow to approximately $7.4 billion in 2011 and nearly $17.5 billion in 2016, a compound annual growth rate (CAGR) of 18.7% over the next 5 years.

To promote a mutual understanding of regional harmonisation initiatives in order to facilitate the harmonisation process related to ICH Guidelines regionally and globally, and to facilitate the capacity of drug regulatory authorities and industry to utilise them. The statistic depicts the worldwide revenue of the pharmaceutical market from 2001 to 2014. In 2001, worldwide revenue was around 390.2 billion U.S. dollars. Ten years later, this figure stood at almost one trillion U.S. dollars.

Since about the year 2000, a growing number of Internet Pharmacies have been established worldwide. Many of these pharmacies are similar to community pharmacies, and in fact, many of them are actually operated by brick-and-mortar community pharmacies that serve consumers online and those that walk in their door. The primary difference is the method by which the medications are requested and received. Some customers consider this to be more convenient and private method rather than traveling to a community drugstore where another customer might overhear about the drugs that they take. Internet pharmacies are also recommended to some patients by their physicians if they are home bound. This statistic shows the channels consumers use for health care, personal care and pharmacy services when shopping in the United Kingdom (UK), as a percentage of survey respondents. Of respondents, 36 percent said they shopped out of town for health, personal care and pharmacy services. This survey was conducted in October 2013.

5^th Global Pharmacists Annual meeting aims to highlight interesting facts from the CEOs & Directors of all promising new-age Pharmaceutical companies and how they managed to create global footprint so a speacial tract 'Enterpreneurs Investment Meet' is designed for the same. The statistic depicts the worldwide revenue of the pharmaceutical market from 2001 to 2014. In 2001, worldwide revenue was around 390.2 billion U.S. dollars. Ten years later, this figure stood at almost one trillion U.S. dollars.